Optimization of Pharmaceutical R&D Programs and Portfolios Design and Investment Strategy /

Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of the published literature comes from the commercial perspective, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book th...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Antonijevic, Zoran (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Need for Optimal Design of Pharmaceutical Programs and Portfolios in Modern Medical Product Development
  • Clinical Aspects of Pharmaceutical Portfolio Management
  • Drug Development and the Cost of Capital
  • Investment Considerations for Pharmaceutical Product Portfolios
  • Challenges of Portfolio Management in Pharmaceutical Development
  • Impact of Phase 2b Strategies on Optimization of Drug Development Programs
  • Using Decision Analysis to Support the Design of Clinical Trials at a Program Level
  • Indication Sequencing for a New Molecular Entity with Multiple Potential Oncology Indications
  • Maximizing Return on Investment in Phase II Proof-of-Concept Trials
  • Portfolio Optimization of Therapies and Their Predictive Biomarkers
  • Dynamically Optimizing Budget Allocation for Phase 3 Drug Development Portfolios Incorporating Uncertainty in the Pipeline.